Product
Ovitrelle
2 clinical trials
4 indications
Indication
infertilityIndication
hCGIndication
BRCA1 MutationIndication
BRCA2 mutationClinical trial
A Randomised, Assessor-blind, Active-controlled, Parallel-group, Dose-finding Trial to Investigate the Efficacy and Safety of FE 999302 for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian StimulationStatus: Withdrawn, Estimated PCD: 2024-03-25
Clinical trial
The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 CarriersStatus: Completed, Estimated PCD: 2018-12-18